FMR LLC 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 5,235,521 14.999% | 1,392,134 (+36.22%) | Filing |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 3,843,387 11.173% | -84,013 (-2.14%) | Filing |
| 2023-02-10 09:08 am Purchase | 2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 3,927,400 11.571% | 975,186 (+33.03%) | Filing |
| 2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 2,952,214 8.698% | -230,487 (-7.24%) | Filing |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 3,182,701 10.762% | 933,868 (+41.53%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | RAPT Therapeutics, Inc. RAPT | FMR LLC | 2,248,833 7.611% | 2,248,833 (New Position) | Filing |